{
 "context": "The following article called 'Cerus reports 4Q loss' was published on 2018-03-08. The body of the article is as follows:\n    \nCONCORD, Calif. (AP) _ Cerus Corp. (CERS) on Thursday reported a loss of $11.5 million in its fourth quarter.\nThe Concord, California-based company said it had a loss of 10 cents per share.\nThe biomedical products company posted revenue of $16.2 million in the period.\nFor the year, the company reported that its loss narrowed to $60.6 million, or 56 cents per share. Revenue was reported as $43.6 million.\nCerus expects full-year revenue in the range of $51 million to $53 million.\nIn the final minutes of trading on Thursday, the company's shares hit $4.77. A year ago, they were trading at $3.91.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on CERS at https://www.zacks.com/ap/CERS\n\n    The day before the article was published, the stock price of Ampco-Pittsburgh Corporation was 11.0 and the day after the article was published, the stock price of Ampco-Pittsburgh Corporation was ",
 "expected": "11.100000381469727",
 "date": "2018-03-08",
 "ticker": "AP",
 "company": "Ampco-Pittsburgh Corporation",
 "url": "https://www.cnbc.com/2018/03/08/the-associated-press-cerus-reports-4q-loss.html"
}